Cancer 'Moonshot' Recommendations On R&D Have Strong Patient Focus

Blue ribbon panel has plenty of industry-friendly recommendations on ways to accelerate oncology science, but with the clock ticking down on the Obama Administration, the question is whether the recommendations have any political traction.